Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrarapid iron polymaltose infusion for iron deficiency anaemia
ACTRN12617001615370Phase 4Completed
- Sponsor
- Iouri Banakh
- Start
- Nov 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of iron polymaltose in iron deficiency anemia (IDA) (3 arms), sponsored by Iouri Banakh. Primary endpoint: Overall adverse event rate. Started Nov 2017; status: completed.
02
Drugs
iron polymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on ACTRN12617001615370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001615370.